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INTRODUCTION 
 
In the world, the most common cause of nutritional anemia is Iron 
deficiency anemia. Children during the phase of rapid growth such as 
preschool and adolescence are at higher risk of developing iron deficiency 
anemia . Rural areas and children from poor socioeconomic status  show 
increased prevalence of iron deficiency .
(1)
 
Iron deficiency is an important problem in patients with cyanotic 
congenital heart disease .In CCHD , arterial oxygen saturation decreases 
and red blood cell count may reach to high level and hyperviscosity 
develops
(2)
. In anemic patients especially those with microcytic iron 
deficiency anemia, permeability of microcyic erythrocytes decreases in 
comparison to normocytic cells, therefore thromboembolic and 
cardiovascular events are encountered more commonly. 
As erythropoiesis and hence haemoglobin ,haematocrit and 
erythrocyte count increases in patients with cyanotic congenital heart 
disease, haemoglobin and haematocrit  are not useful indicators of iron 
deficiency anaemia. 
In children with  cyanotic congenital heart disease, when there is 
decreasing arterial oxygen saturation, it  causes compensatory increase in 
haemoglobin and haematocrit levels. Iron deficiency causes discrepant 
 
 
values for arterial oxygen saturation and haemoglobin/haematocrit and that 
"normal" haemoglobin/haematocrit levels in such children may constitute 
anaemia
(3)
. In CCHD, normal hemoglobin represent relative anemia and 
may have disastrous effects. The normal postnatal fall in haemoglobin 
levels that occurs in neonates will not occur if arterial desaturation is 
marked from birth ,although relative anaemia in this situation develops by 
the third  or fourth month of life
(4)
.The bone marrow normally responds to 
hypoxia  by increasing erythropoiesis, with an increase in red cell count, 
haemoglobin level and haematocrit. The consequences of iron deficiency 
anaemia in cyanotic heart disease are dire, either in infancy or later.  
Metabolic acidosis, and cyanotic attacks  are exacerbated by the presence 
of  iron deficiency anaemia . Similarly very high counts of red blood cells, 
blood viscosity is increased, and with it  the tendency to cerebrovascular 
accidents. When the haematocrit is above 60%,further small increases 
produces large increments in viscosity
(5)
. At a haematocrit level of 70% , 
blood viscosity is so high that fluidity in small vessel becomes 
critical.Measurements of MCV, MCH and serum ferritin reveal the 
existence of iron deficiency anaemia. In this study we made an attempt to  
study the children with cyanotic congenital heart disease ,by simple tests 
like complete hemogram and red cell indices and ascertain if it be enough 
to diagnose iron deficiency than the more expensive diagnostic tests like 
serum iron, total iron binding capacity and serum ferritin levels. 
 
 
AIMS AND OBJECTIVES 
 
a) To study prevalence of iron deficiency anaemia in children having 
cyanotic congenital heart disease 
b) To assess various biochemical and hematological parameters of 
iron status in children having cyanotic congenital heart disease 
 
 
 
 
 
 
 
 
 
 
INCLUSION CRITERIA 
1) All proven case of cyanotic congenital heart disease by history , 
examination   and echocardiography 
2) Age of children between 6 months and 12 years.    
 
EXCLUSION CRITERIA 
1) Children less than 6 months of age 
2) Post operative patients 
3) Patients with chronic infectious diseases 
 
 
 
 
 
 
 
 
MATERIALS  AND METHODS   
 
50 Children aged between  6 months to 12 cyanotic congenital heart 
disease were studied .Written  informed consent obtained  from their 
parents. Infants less than 6 months were excluded ,so that measurements 
would not be influenced by haematological changes at birth and the nadir 
of physiological anaemia of infancy was avoided. 
Details were recorded on a pre- designed proforma. Detailed 
Medical history was taken. Previous medical records were analyzed& 
recorded. Complete clinical examination was done with specific emphasis 
regarding complications of iron deficiency and cyanotic congenital heart 
disease like focal neurological deficits and brain abscess. 
Radiological investigations  including  x ray chest, 
electrocardiogram, two dimensional  echocardiography  were done and 
evaluated by radiologist and cardiologist. 
Blood samples collected for relevant investigations : 
Haematological measurements included complete hemogram,   
peripheral smear,red cell indices. These tests were done by coulter 
machine. 
 
 
 Biochemical parameters included  serum iron ,total binding 
capacity, transferrin saturation  and serum ferritin. These tests were done 
using spectrophotometric measurements.  
Transferrin saturation of < 16%  categorized as iron deficient,and  > 
16%  categorized as iron sufficient. The various parameters like age , sex, 
haemoglobin, haematocrit ,MCV,MCH,MCHC, RDW,Platelet count , 
serum iron ,total binding capacity, transferrin saturation  and serum ferritin 
were compared between the iron deficient and iron sufficient group. 
Results were tabulated and statistical analysis  was done. 
 
  
 
 
REVIEW OF LITERATURE 
Congenital heart defects are the most common type of birth defects, 
affecting 8 out of every 1000 newborns
(6)
. various studies on congenital 
heart disease both cyanotic and acyanotic and its correlation with iron 
status have been studied by various authors. A short literature  is as 
follows. 
Embryology: 
There is a complex sequence of events that result in a well formed 
heart at birth and disruption of any portion may result in a defect
(61)
. 
Around day 15 of development, the cells that will become the heart exist in 
two horse shoe shaped bands of middle tissue layer(mesoderm) 
(62)
. On day 
19, a pair of vascular elements ,theendocardial tubes form,which fuse to 
form a ring of heart cells(myocytes) around it by day 21. On day 22, the 
heart begins to beat and by day 24, blood is circulating 
(63).
At  day 22, the 
circulating system is bilaterally symmetrical with paired vessels on each 
side and heart consisting of a single tube. From day 23 -28, heart tube folds 
and twists, with the future ventricles moving left of center and atria 
moving towards the head. On day 28, the membranous septum 
septumprimum and muscular endocardial cushions, fuse to form the four 
heart chambers of the heart. After this, the neural crest divide the bulbous 
 
 
cordis into two by the growth of spiralling septum and becomes the great 
vessels – the ascending segment of aorta and the pulmonary trunk. If 
separation is incomplete, the result is a persistent truncusarteriosus. The 
vessels may be reversed as in transposition of great vessels. A small vessel, 
the ductusarteriosus allows blood from pulmonary artery to pass to the 
aorta.
(63)
 
GENETICS : 
Most of the known causes of congenital heart disease are sporadic 
genetic changes, either focal mutations or deletion or addition of segments 
of  DNA. (
64
) major chromosomal abnormalities such as trisomy 21,13 and 
18 cause about 5 to 8 % of CHD, with trisomy 21 being the most common. 
Mutations of a heart muscle protein, a – myosin heavy chain(MYH6) are 
associated with atrial septal defects . mutations in NKX2-5 gene is 
associated with defects in the electrical conduction of the heart and TBX5 
is related to holt-oram syndrome.T1BX, is involved in velo-cardio-facial 
syndrome and digeorge syndrome. 
Mutations in jagged 1 are identified in cases of arterio hepatic 
dysplasia (Alagille syndrome). Mutations of cell regulatory mechanism , 
the Ras/MAPK pathway are responsible for noonan syndrome, leopard 
syndrome, Costello syndrome and cardio-facio-cutaneous syndrome. 
known antenatal risk factors include maternal infections(rubella), drugs     
 
 
(alcohol, hydantoin,lithium and thalidomide) and maternal illness(diabetes 
mellitus,phenylketonuria and systemic lupus erythematosus). 
Congenital heart disease are broadly classified as acyanotic  and 
cyanotic congenital heart disease.cyanotic heart disease is further classified 
as conditions with decreased blood flow like tricuspid atresia, tetralogy of 
fallot, single ventricle with pulmonary stenosis ,isolated pulmonary 
stenosis and conditions with increased blood flow includes transposition of 
great vessels,total anomalous pulmonary venous connection,single 
ventricle and single atrium. 
 
 
 
 
 
 
 
 
 
 
 
Cyanosis is a bluish discolouration of skin and mucous membrane 
resulting from an increased concentration of reduced hemoglobin to about 
5 g/dl  in the cutaneous veins. The level of reduced hemoglobin in 
cutaneous veins may result  from either desaturation of arterial blood or 
increased extraction of oxygen from peripheral tissue in the presence of  
normal arterial saturation(circulatory shock, hypovolemia ,vasoconstriction 
from cold).Cyanosis associated with desaturation of arterial blood is called 
central cyanosis. Cyanosis with a normal arterial saturation is called 
peripheral cyanosis. 
An arterial oxygen saturation of 90% or above does not rule out a 
cyanotic heart disease in a newborn infant. An arterial oxygen saturation of 
90 % can be seen with po2 of 45 to 50 mm Hg in newborns because of a 
normally leftward oxygen hemoglobin dissociation curve .in older children 
and adults, a Po2 of 60 to 65 mm Hg is needed to have 90 % oxygen 
saturation. 
 
 
 
 
 
 
 
 
CONSEQUENCES AND COMPLICATIONS OF CYANOSIS 
POLYCYTHEMIA: 
Low  arterial oxygen content stimulates bone marrow through 
erythropoietin release from the kidneys and produces an increased number 
of red blood cells. Polycythemia , with a resulting increase in oxygen-
carrying capacity , benefits cyanotic children . However, when the 
haematocrit reaches 65 % or  higher, a sharp increase in the viscosity of 
blood occurs, and the polycythemic response becomes disadvantageous, 
particularly if the is congestive heart failure. Some cyanotic infants have a 
relative iron deficiency state,with a normal or lower than normal 
hemoglobin and hypochromia on peripheral smear. A normal hemoglobin 
in a cyanotic patient represents relative anaemic state. Although less 
cyanotic , these infants are usually more symptomatic and improve when 
iron therapy raises the hemoglobin. 
CLUBBING: 
Clubbing is caused by soft tissue growth under the nail bed as a 
consequence of central cyanosis. The mechanism of soft tissue growth is 
unclear. One hypothesis is that megakaryocytes present in systemic venous 
blood may be responsible for the change. In normal persons , platelets are 
formed from the cytoplasm of the megakaryocytes by fragmentation   
 
 
during their  normal passage through the pulmonary circulation. The 
cytoplasm of megakaryocytes contains growth factors ( eg. Platelet derived 
growth factor and transforming growth factor ß) . In patients with right –to 
left shunts, megakaryocytes with their cytoplasm may enter the systemic 
circulation, become trapped in the capillaries of the digits, and release 
growth factors, which in turn cause clubbing. Clubbing usually does not 
occur until a child is 6 months or older, and it is seen first and is most 
pronounced in the thumb. In the early stage, it appears as shininess and 
redness of the finger tips.  When it is fully developed , the fingers and toes 
become thick and wide and have convex nails. 
CENTRAL NERVOUS SYSTEM COMPLICATIONS : 
Either very high  haematocrit  level or iron-deficient red blood cells 
place individuals with cyanotic congenital heart defects at risk for 
disorders of the central nervous system, such as brain abscess and vascular 
stroke. In the past, cyanotic  CHD s account for 5% to 10 % of all cases of 
brain abscesses. The predisposition for brain abscesses may partially result 
from the fact that right-to-left intra cardiac shunts may bypass the normally 
effective phagocytic filtering actions of the pulmonary capillary bed. This 
predisposition may also result from the fact that polycythemia and the 
consequent high viscosity of blood lead to tissue hypoxia and micro 
infarction of the brain, which are complicated by bacterial colonization 
 
 
.The triad of symptoms of  brain abscesses are fever, headache, and focal 
neurologic deficit. Vascular stroke caused by embolization arising from 
thrombus in the cardiac chamber or in the systemic veins may be 
associated with surgery or cardiac catheterization. Cerebral venous 
thrombosis may occur, often in infants younger than 2 years who have 
cyanosis and relative iron deficiency anemia. A possible explanation for 
these findings is that microcytosis further exacerbates hyperviscosity 
resulting from polycythemia. 
BLEEDING DISORDERS : 
Disturbances of  haemostasis are frequently present in children with 
severe cyanosis and polycythemia . Most frequently noted are 
thrombocytopenia and defective platelet aggregation . Other abnormalities 
include prolonged prothrombin time and partial thromboplastin time and 
lower levels of fibrinogen and factors V and VIII . Clinical manifestations 
may include easy bruising, petechiaeof  the skin and mucous membranes, 
epistaxis, and gingival bleeding. 
HYPOXIC SPELLS AND SQUATTING : 
Although most frequently seen in infants with Tetralogy of  Fallot 
(TOF), hypoxic spells may occur in infants with other congenital heart 
defects. 
 
 
DEPRESSED INTELLIGENT QUOTIENT: 
Children with chronic hypoxia and cyanosis have a lower than 
expected intelligence quotient as well as poorer perceptual and gross motor 
functions than children with acyanotic  congenital heart defects, even after 
surgical repair of  cyanotic heart defects. 
SCOLIOSIS : 
Children with chronic cyanosis, particularly girls and in patients 
with TOF, often have scoliosis. 
HYPERURICEMIA AND GOUT : 
Hyperuricemia and gout  tend to occur in older patients with 
uncorrected or inadequately repaired cyanotic heart defects.       
 
 
 
 
 
 
 
 
 
 
HAEMATOLOGICAL MANIFESTATIONS OF CONGENITAL 
CYANOTIC HEART DISEASE: 
 
Erythrocyte disturbances in children with cardiac disease must be 
understood in the context of compensatory states or the context of iron 
deficiency as a complication. In infants with cyanotic congenital heart 
disease have erythropoietin-induced compensatory polycythemia. aortic 
oxygen saturation higher than 80% is usually associated with low 
erythropoietin titres and haemoglobin levels that will not cause 
hyperviscosity. Even with moderate degrees of hypoxemia ,elevated 
erythropoietin levels are not seen;presumably modest elevation  in 
haemoglobin  levels provide adequate tissue oxygenation. 
(15-17)
. Infants 
with cyanotic congenital heart disease have higher iron requirements 
because of greater haemoglobin mass.diminished iron stores are associated 
with more right-shifted oxyhemoglobin dissociation curve
(21)
.Most 
children with cyanotic congenital heart disease have evidence of mild 
macrocytosis. A mean corpuscular volume greater than the 90th  percentile 
for age and sex nearly eliminates the possibility of iron deficiency.
(18)
 
Haematological adaptations to maintain transport of oxygen to 
metabolizing tissues include excessive erythropoiesis which may lead to 
polycythemia and hyperviscosity
(5)
.There is high incidence of 
cerebrovascular accidents in children with cyanotic congenital heart 
 
 
disease. Hyperviscosity  alone may acount for some ischaemic infarctions. 
The possibility of neurologic defects  after the onset of  iron deficiency in 
the presence of polycythemia have been described
(19,20)
.Card and 
Weintraub showed that altered deformability in the presence of increased 
blood viscosity could result in vascular ischaemia.
(21)
 
Cyanotic heart disease may result in poor perfusion of the spleen 
and subsequent functional hyposplenism manifested by howell-jolly bodies 
in peripheral blood.
(22)
 
Coagulation abnormalities : 
     Many investigations have suggested  that a coagulopathy exists in some 
patients with cyanotic congenital heart disease. Thrombocytopenia,low 
plasma fibrinogen levels,defective clot retraction ,hypoprothrobinemia, 
factor V and VIII deficiency, and evidence  of fibrin degradation products 
in serum have been reported.
(23-27)
 
Dennis and associates 
(28)
 were the first to report five patients with 
cyanotic congenital heart disease associated with coagulation 
abnormalities that were correctable by heparin. The presence of 
coagulation abnormalities correlates with the extent of polycythemia.
(29)
 
The exact mechanism producing the coagulopathy is not known and could 
 
 
be multifactorial in origin. Hyper viscosity  may lead to tissue 
hypoxemia,which then triggers a consumptive process.
(30)
 
Platelet abnormalities : 
Quantitative and qualitative platelet abnormalities are commonly 
associated with cardiac disease. In one study,the mean platelet count in 
cyanotic patients with an arterial oxygen saturation of less than 60% was 
1,85,000 cells/cu.mm as compared with 3,15,000 cells/cu.mm in patients 
with an arterial oxygen saturation greater than 60% 
(31,32)
. Examination of 
bone marrow has failed to demonstrate any quantitative changes in 
megakaryocytes to account for these platelet differences
(31)
.This, together 
with  the finding of shortened platelet survival in many patients, has 
suggested that the mechanism of the thrombocytopenia is destructive.it 
should be noted that although iron deficiency is commonly associated with 
cyanotic heart disease ,the quantitative platelet abnormalities are not 
related to iron status. 
     Qualitative platelet defects associated with cyanotic congenital heart 
disease may include prolonged bleeding times and abnormal aggregation  
in response to adenosine diphosphate,epinephrine and collagen
(33)
. These 
platelet functional abnormalities appear to be due to a defective platelet 
release mechanism because diminished release of [ 
14
C]  serotonin occurs 
in response to adenosine diphosphate whereas uptake of [
14
C]  serotonin  is 
 
 
normal
(34)
. Platelet release abnormalities are common in patients older than 
4 years, in those with platelet counts less than 1,75,000 cells/cu.mm. There 
is no correlation between abnormalities in platelet aggregation and release 
and abnormal bleeding time. 
Iron is a critical element in the function of all cells, although the 
amount of iron required by individual tissues varies during development. 
This plebeian metal is vital to the function of critical enzymes, including 
catalases, aconitases, ribonucleotidereductase, peroxidases, and 
cytochromes, that exploit the flexible redox chemistry of iron to execute a 
number of chemical reactions essential for our survival
(7)
. 
IRON DEFICIENCY ANAEMIA : 
Iron deficiency anaemia is defined as anaemia caused by inadequate 
availability of iron to sustain bone marrow erythropoiesis. Anaemia caused 
by iron deficiency is the most common hematologic disease of infancy and 
childhood .the body of the newborn infant contains 0.3 to 0.5 g of iron; the 
body of  an adult contains upto 5 g. to make up the 4.5 g difference, an 
average net increase of 0.5 mg of iron must be absorbed each day during 
the first 15 years of life. In addition to this requirement for growth,a small 
amount of iron is necessary to balance the normal losses, estimated at 0.5 
to 1 mg/day. To maintain a positive iron balance during childhood , 0.8 to 
 
 
1.5 mg of iron must be absorbed each day from the diet. Because less than 
10% of dietary iron is absorbed from the average mixed diet, 8 to 15 mg of 
iron daily is necessary for optimal nutrition.
(8)
 
According to the fourth national health and nutrition examination 
survey (NHANES IV) , iron deficiency without anaemia  exists in 7% of 
toddlers aged 1 to 2 years, 9% of adolescent girls, and 16% of women of 
child bearing age
(9)
. 
  Socioeconomic factors are associated with iron deficiency anaemia 
in children. For example, infants and children of low-income and minority 
backgrounds have higher documented rates of iron deficiency     
anaemia.
(10-12)
 
The prevalence of iron deficiency anaemia in developing countries 
like India has been found to be as high as 63% in 1-3 years group of 3-6 
years as per study by ICMR in 1977.More recent report of the NFHS-3 
shows that the prevalence has not much changed in 2005-2006 and is still 
73% among children of 6-35 months of age.Iron deficiency anaemia is 
most common in the age group of 6 months to 3 years of age.Breast milk 
contains iron with high bioavailability and hence iron deficiency anaemia 
is uncommon in exclusively breast fed infants before 4-6 months of 
age.Whereas non introduction of iron containing of weaning foods or 
 
 
continuation of only milk feeds,especially more than 16 oz.per day and 
that too with feeding bottle,leads to iron deficiency anaemia in 
infants.anaemia due to worms especially hook worms is very common in 
poor socioeconomic groups of patients.World Health Organization 
recommends use of palmar pallor as a screening measure for anaemia.In 
mild anaemia there may be no signs and symptoms but in severe 
deficiency, all the symptoms of anaemia like fatigue, breathlessness, 
irritability, anorexia, etc. may be seen. Pica usually is the manifestation of 
iron deficiency and relieved when condition is treated. Epithelial changes 
like koilonychias, platynachia, angularstomatitis, atropic gastritis, mucosal 
changes in the stomach leading to atropic gastritis and achlorhydria and 
small bowel leading to esophageal mucosal webs as seen in Plummer 
Wilson syndrome.These changes are rarely seen in children with iron 
deficiency and are more common in adolescent with nutritional 
anaemia.There is marked reduction in weight in iron deficient 
children,Though height seems to be unaffected.Work output falls 
significantly due to iron deficiency anaemia.Besidesanaemia, iron 
deficiency leads to many other systemic effects;Notable amongst them is 
its effect on growing brain where it has been shown to lead to cognitive 
dysfunction,  which is sometime permanent.Thesebehavioural changes 
occur due to diminished activity of aldehyde  oxidase, required for the 
serotonin catabolism,thus leading to increase level of serotonin and 6 –
 
 
hydroxyindolecompounds. Reduced attention span, irritability,decreased 
scholastic performance, poor academic achievement and conduct disorder 
occur in these iron deficient children. Humoral, cell mediated and 
nonspecific immunity and the activity of the cytokinesis which have an 
important role in various steps of immunogenic mechanisms are influenced 
by iron deficiency anaemia. This is simply avoidable by simple treatment 
with iron which is cost effective and easily available medicine, provided 
we realize the importance of treating infants with iron deficiency promptly 
and effectively. 
IRON METABOLISM  
There are two major sources of food iron: Heme iron and 
nonhemeiron. Heme iron is highly bio-available and is present in 
meat,fish, poultry as well as in blood products. nonheme iron is a more 
important source and is found to varying degrees in all foods of plant 
origin. Maximum amount of iron is absorbed from the duodenum. two 
steps are involved in the absorption of iron: entry of iron from the 
intestinal lumen into the mucosal cells and its passage from mucosal cell 
into the plasma. only a fraction of iron that enters the mucosal cells finds 
its way to the plasma the remainder being held in the cell as ferritin which 
is lost from the body as the mucosal cell is desquamated into the lumen at 
the end of its i.e 3-4 days. With increased iron stores there is increased 
 
 
transferrin saturation and increased messenger iron in the mucosal cell.this 
messenger iron stimulates the production of apoferritin.Thus whenever 
there is increase in transferrin saturation,a large fraction of iron entering 
the mucosal cell is held back as ferritin and discorded,as the cell is 
desquamated.excessive accumulation of iron by absorption is thus 
prevented. 
PHASES OF DEVELOPMENT OF IRON DEFICIENCY : 
  Most of the body`s iron is directed towards synthesis of 
haemoglobin, erythrocyte  production is among the first casualities of iron 
deficiency to become clinically apparent in usual laboratory evaluations. 
iron deficiency progresses through three discernible phases: 
1. Prelatent iron deficiency  occurs when tissue stores are depleted, 
without a change in haematocrit or serum iron levels. This stage of 
iron deficiency may be detected by low serum ferritin 
measurements. 
2. Latent iron deficiency occurs when the reticuloendothelial 
macrophage iron stores are depleted. The serum iron level drops and 
TIBC increases without a change in haematocrit. This stage may be 
detected by routine checking of fasting, early morning transferrin 
saturation .erythropoiesis begins to be limited by a lack of available 
 
 
iron, and sTfR levels increase . the reticulocyte haemoglobin content 
(CHr) decreases because newly produced erythrocytes are iron 
deficient
(13)
.The bulk of the erythrocyte population appears normal.  
3. Frank iron deficiency anaemia is associated with erythrocyte 
microcytosis and hypochromia. It is detected when iron deficiency 
has persisted long enough that a large proportion of the circulating 
erythrocytes were produced after iron became limiting.
(13,14)
 
 
 
 
 
 
 
 
 
 
 
 
STAGES IN THE DEVELOPMENT OF IRON DEFICIENCY 
ANEMIA 
  Stage 1  Stage 2  Stage 3 
  PRELATENT  LATENT ANEMIA 
Bone marrow iron  Reduced  Absent  Absent  
 Serum ferritin  Reduced  < 15 μg/l >15 μg/l 
Transferrin saturation Normal < 16 % >16 % 
Free 
erythrocyticprotoporphyrin 
Normal Increased  Increased 
Seru transferrin receptor Normal Increased Increased 
Reticulocyte haemoglobin 
content 
Normal Decreased  Decreased 
Haemoglobin Normal Normal Reduced  
MCV Normal Normal Reduced 
Symptoms  Fatigue, 
malaise 
Fatigue, 
malaise 
Pallor,pica, 
epithelial 
changes 
 
 
 
 
 
LABORATORY ASSESSMENT OF BODY IRON STORES: 
1. HAEMOGLOBIN : 
     Haemoglobin is the red , oxygen carrying pigment in the red blood 
cells. Haematocrit values are roughly equivalent to three times 
haemoglobin concentration. Child is said to be anaemic when these 
levels are two standard deviation below the mean for the particular age 
and sex. 
2. RED CELL INDICES :
(35)
 
a) MEAN CORPUSCULAR VOLUME  
It is expressed as volume of red cells 
MCV (fl) =Hct * 10/RBC (10
6
/µl) 
NORMAL RANGE: Normocytic 75-100 fl 
In iron deficiency it is microcytic and < 72 in children. 
b) MEAN CORPUSCULAR HEMOGLOBIN : 
It is the amount of haemoglobin per red blood cell 
MCH(pg) =Hb *10/ RBC (10
6
/µl) 
Normal range : 30 +/-4 
In iron deficiency anaemia it is < 31 g/dl 
 
 
 
 
C)MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION : 
It is the average concentration of haemoglobin in the red cells 
MCHC(g/dl) =Hb *100/ Hct 
Normal range : 31-37 g/dl 
In iron deficiency anaemia it is < 31 g/dl 
d) RED CELL DISTRIBUTION WIDTH( RDW): 
Red cell distribution width Is the variability in the red cell 
volume. 
In iron deficiency anaemia it is > 14.5 % 
It is more sensitive(90-100%)  and less specific(50-70%). 
3) SERUM IRON AND TOTAL IRON BINDING CAPACITY: 
Serum iron level represents the amount of circulating iron bound to 
transferrin . The TIBC is an indirect measure of the circulating transferrin. 
Normal range for serum iron : 50 – 150 µg/dl 
Normal range for TIBC : 300 -360 µg/dl 
4) TRANSFERRIN SATURATION : 
Transferrin saturation  = serum iron * 100/ TIBC 
A Transferrin saturation of  < 16% is considered iron deficient. 
 
 
Age Hb(g%) 
Mean 
(-2 SD) 
Hct% 
Mean 
(-
2SD) 
RBC(mill/cu.mm) 
Mean 
(-2 SD) 
MCV(fl) 
Mean 
(-2SD) 
MCH(pg) 
Mean 
(- 2SD) 
MCHC(g/dl) 
Mean 
(-2 SD) 
6 
mon– 
2 yr 
12(11) 36(33) 4.5(3.7) 78(70) 27(23) 33(30) 
2-6 
yrs 
12.5(11.5) 37(34) 4.6(3.9) 81(75) 27(24) 34(31) 
6-12 
yrs 
13.5(11.5) 40(35) 4.6(4.0) 86(77) 29(25) 34(31) 
 
5) SERUM FERRITIN :
(36)
 
Iron is stored complexed to protein as ferritin within cells 
To estimate iron stores,serum ferritin is an important laboratory 
investigation. 
Serum ferritin levels <15 ng/dl are diagnostic of iron deficient 
anaemia and absent iron stores. 
6) RED CELL PROTOPORPHYRIN LEVELS : 
Red cell protoporphyrinlevels  reflects an inadequate iron supply to 
erythroid precursors to support haemoglobin synthesis. 
Normal values are  <30 µg/dl .in iron deficiency it is > 100 µg/dl. 
 
 
 
7) TRANSFERRIN RECEPTOR PROTEIN LEVELS : 
Serum levels of transferrin receptor protein reflects the total 
erythroid marrow mass.It is determined by radioimmuno assay. 
Normal values are 4 -9 µg/L , it is elevated in iron deficiency anaemia 
8) FREE ERYTHROCYTIC PROTOPORPHYRIN AND 
PROTOPORPHYRIN : HEME (P: H) RATIO : 
It indicates  thesupply of iron  to the red cells  over a prolonged  
period . 
Normal range  of free erythrocyticprotoporphyrin  30- 40 µg/dl RBC 
and P:H ratio is  16 (=/- 5.3) 
  Free erythrocyticprotoporphyrin above 70 µg/dl RBC and P:H ratio 
above 32 is considered iron deficiency. 
9) RETICULOCYTE HEMOGLOBIN CONTENT : 
It is a new method for diagnosing iron deficiency anaemia, which is 
diagnosed by bone marrow examination.Response to therapy becomes the 
diagnostic measure. A positive response is defined as daily increment of 
0.1 mg/dl of haemoglobin from fourth day onwards. 
 
 
 
 
Several studies have been studied on cyanotic congenital heart disease in 
children , But few studies were done on Iron deficiency anaemia in 
children with cyanotic congenital heart disease. Here are some studies: 
Onur CB
(37)
  et al determined the incidence of iron deficiency in 
children with cyanotic congenital heart disease in 44 children with 
cyanotic congenital heart disease .The prevalence of iron deficiencyanemia  
was 63.6%. They concluded  that MCV,MCH,RDW are useful indicators 
of iron deficiency than hemoglobin (Hb), hematocrit (Hct) and red blood 
cell (RBC) . 
OlcayL
(38)
 et al studied a  group of 67 children with cyanotic 
congenital heart disease . Among the 67 patients with CCHD whose 
haematocrit was < 60 %,  prevalence of iron deficiency was 52.2% .Out of 
this, iron treatment  was given to 35 patients who had MCV < 60 by 6 
mg/kg/day. Post  treatment values were taken . Hemoglobin and 
haematocrit with RBC count had significant correlation. They concluded 
that Hemoglobin (Hb), hematocrit (Hct) , mean corpuscular haemoglobin 
and RBC count are useful measurements for diagnosis of iron deficiency 
anaemia in children with cyanotic congenital heart disease. 
Drossos  et al
(39)
 determined  Hemoglobin (Hb), hematocrit (Hct) 
and mean corpuscular hemoglobin concentration (MCHC),serum iron  in 
 
 
74 children (including both acyanotic and  cyanotic) with congenital heart 
disease. Using serum iron as a predictor, incidence of anaemia was found 
as 37.5% for < 5 years and 12.5 % for 6-12 years. . Using MCHC as a 
predictor , incidence of anaemia was found  as 44% for < 5 years and 23.8 
% for 6-12 years. The data shows  that the MCHC is a precise indicator of 
iron deficiency anaemia in children with cyanotic heart disease and  that 
the incidence of hypochromic anaemia is high in cyanotic patients. 
Lang'oMO
(40)
 et al  examined the haematological profile of children 
with cyanotic heart disease and to document the prevalence of abnormal 
coagulation and iron deficiency in these children. The prevalence of iron 
deficiency was found to be 16.9% , Prolonged APTT- 32.1%, prolonged 
PT-3.6%, low platelets-7.1%, and raised D-dimer - 60% 
 
The sensitivity of Low MCV in detecting iron deficiency was 58.8% 
with a specificity of 51.2%. For Low MCH the sensitivity was 52.9% with 
a specificity of 50.6%. Findings of microcytic hypochromic anemia on 
peripheral blood film gave a sensitivity of 50% and specificity of 73.4%. 
 
Braun SL  Et al
(41)
studied that due to chronic hypoxia,to improve 
oxygen transportation, the adaptive response which occurs is 
erythrocytosis. Due to this the haematocrit levels increase leading to 
symptoms of hyperviscosity. Due to elevated haemoglobin concentration 
 
 
iron deficiency is often underestimated. Hence for institution of accurate 
management and avoid errors, iron status must be accomplished by 
biochemical parameters. 
Samia H. Osman, MD et al
(42)
 stated that, Children with cyanotic 
heart disease have deficient oxygen transport to tissues that might be 
complicated by polycythaemia with the potential risk of brain injury and 
abnormal haemostatic mechanisms: thrombis or bleeding diathesis. Thirty-
one patients were seen during the study, 19 were males and 12 were 
females. The complications were: iron deficiency in two-thirds of the 
cases, poylcythaemia in half of the cases, low serum ferritin and prolonged 
INR in one third of the cases. Thrombocytopenia and prolonged bleeding 
time was detected in 12% of the cases. Significant correlation between 
polycythemia and the oxygen saturation was detected (p= 0.03). No 
significant correlation was found between the prolonged INR and the age, 
duration of CCHD since diagnosis, type of CCHD and the oxygen 
saturation. 
Haga P et al
(3)
 between arterial oxygen saturation  and haemoglobin 
and haematocrit. Measurements of MCV,MCH and serum ferritin reveal 
the existence of iron deficiency anaemia. 
 
 
 
S. Roodepeyma et al
(43)
 studied the red cell indicies in patients with 
cyanotic heart disease. 11 patients had MCV < 3 rd percentile for age and 
sex, MCH and MCHC < 3 rd percentile in 44.4% and 62% respectively. 
Hypochromia is more prevalent than microcytosis in patients. 
David W.West et al
(44)
 studied  the risk of iron deficiency in children 
with CCHD < 6 years. In their study 50% of children had iron depletion 
30% had iron deficiency with anaemia ,who were younger than those 
without iron deficiency.  
Gaiha M et al 
(45)
studied the hematological parameters of iron 
deficiency anaemia and its correlation with hyperviscosity symptoms in 
CCHD in 33 cases and to assess the response to low dose iron therapy. 
Results showed presence of IDA is18.2%,hyperviscosity symptoms is 30.3 
% and low dose iron therapy was found effective in relieving the 
symptoms of hyperviscosity. 
Otwin Linderkamp et al
(46)
 studied 59 children with various cyanotic 
congenital heart disease for hyperviscosity and effect of microcytosis on 
the viscosity of blood. 
The chance of developing hyperviscous blood and risk of 
cerebrovascular complications were higher due to iron deficient RBCs 
which were microcytic in morphology. 
 
 
Charlie Phornphutkul et al
(47)
 reviewed 30 cases of CCHD to 
determine the risk of cerebrovascular accidents. The overall incidence was 
1.6 %. 90 % of cerebrovascular accidents occurred in patients with TOF 
and dextroposition of the great arteries. Cerebrovascular accidents in less 
than 4 years of age was associated with anaemia (low MCHC) and 
hypoxemia ,in contrast in older children it was associated with 
polycythemia and hypoxemia. 
Robert R. Martelle et al
(48)
 studied 50 patients with CCHD for 
Cerebrovascular accidents. They found that no correlation between 
haematocrit and occurrence of CVA. 
Nassar Amash et al
(49)
 studied 162 adults with CCHD for incidence 
of Cerebrovascular accidents .There was increased risk of CVA associated 
with microcytosis (p <0.01). They concluded treating microcytosis is 
necessary. 
D.W .Miligan et al
(50)
 studied the impact of red cell indices on 
viscosity of blood in polycythemic patients.  The results of this study was 
that  reduction of MCH or MCV  leads to increased viscosity of blood due 
to cell to cell interaction. 
 
 
 
Milton H. Paul et al 
(51)
studied about the association of 
thrombocytopenia with that of CCHD. They studied 200 patients and 
found that thrombocytopenia is rare unless haematocrit was > 65% or 
oxygen tension < 70%. Incidence of thrombocytopenia under 1 year of age 
was 10% whereas in more than 1 year ,it was 60 %. 
Hitoshi Horigome et al
(52)
 studied the role of platelets in the 
pathogenesis of abnormal coagulation in the patients with CCHD with 
polycythemia. Results showed production of microparticles correlated 
positively with haematocrit and markedly increased at haematocrit above 
60% in patients with CCHD. Hence they concluded that circulating 
incompetent platelets as well as microparticles , might play a role in 
coagulation abnormalities. 
Anne L.Wedemeyer et al
(53)
 studied thecoagulation abnormalities in  
33 CCHD with haematocrit > 45 %,age group 5 months -15 years and 
body weight >6 kgs .results showed that thrombocytopenia was common 
with haematocrit of 65% and rare when haematocrit was > 65%. The 
severity of thrombocytopenia  was related to polycythemia. Patients with a 
haematocrit of 60 -70 % had higher incidence of thrombocytopenia , 
abnormal clot retraction, shortened euglobin clot lysis time and presence of 
fibrin degradation products. 
 
 
Forest H .Adams
(54)
, M.D. et al studied 18 children with moderate to 
severe cyanotic heart disease for the haemoglobin,the red blood cell count, 
the haematocrit ,the mean corpuscular diameter and the carbonic anhydrase 
content of the cells. their study  showed that polycythemia in such children 
is not associated any changes in red cell size or carbonic anhydrase 
content. 
ShelonitaS.Rose
(55)
 et all studied cyanotic heart disease with 
symptomatic erythrocytosis and concluded that the treatment is volume 
replacement and low dose iron therapy. Because repeated phlebotomy 
causes iron deficiency with microcytic erythrocytes,which increases the 
viscosity of blood and increase the risk for cerebrovascular accident. 
Edgar L W Tay
(56)
 et al studied 25 adult with iron deficiency 
anaemia and gave oral ferrous fumarate. After 3 months of therapy in iron 
deficient patients, resulted in improvement in exercise tolerance and 
quality of life. 
Michael H. Rosove
(57)
 et al studied in adults with cyanotic 
congenital heart disease for decompensated erythrocytosis and iron 
supplementation was given for these patients.Despite the normal levels of 
iron and ferritin, microcytosis, hypochromia  and raised erythrocyte 
protoporphyrin persisted ,representing failure of iron procurement and 
 
 
delivery system in an extreme cases of erythroid hyperplasia induced by 
hypoxemia. 
Jonathon L. Maguire 
(58)
et al did a study from stroke registry  and 
concluded that iron deficient children are 10 times more risk for stroke 
than iron sufficient children. 
Andrea Sherriff 
(59)
et al did study to define the normal ranges and 
investigated the associated factors for haemoglobin and ferritin 
concentration at 8, 12 and 18 months of age. According to their study a 
definition of anaemia based on the fifth centile gives a cut off point at 12 
and 18 months of age of haemoglobin < 10 g/dl and for iron deficiency of 
ferritin < 16μg/L and < 12 μg respectively.  
Samuel S.Gidding
(60)
 et al from their study done in children 
memorial hospital , concluded that  patients with high erythropoietin titres  
had lower paO2, lower aortic saturation and higher red cell 2,3 DPG. The 
relationship between aortic oxygen saturation and haemoglobin saturation 
was strong. 
 
 
 
  
 
 
STUDY DESIGN 
Prospective analytical study done in a tertiary care hospital for aperiod 
between October  2011 –November 2012 
STATISTICAL ANALYSIS 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2010) 
developed by Centre for Disease Control, Atlanta.  
Using this software range, frequencies, percentages, means, standard 
deviations, chi square and 'p'  values were calculated. Pearson chi-square  
test, Fisher exact test  was used to test the significance of difference 
between quantitative variables. A 'p' value less than 0.05 is taken to denote 
significant relationship. 
  
 
 
 
 
 
 
 
 
RESULTS 
 
Totally 50 children were studied during the study period.  
 Table 1 :Distribution  among  cases -age (years) : 
 
Age(years)       No. Percentage  
< 1        12     24% 
1 to 6        24     48% 
6 to 12       14     28% 
Total        50    100% 
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Table 2 : Distribution of cases among sex 
 
Sex  No. Percentage  
Male  25 50% 
Female  25 50% 
Total  50 100% 
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Table 3 : Distribution of cases - Cyanosis 
 
Cyanosis No. Percentage  
Present 40 80% 
Absent  10 20% 
Total  50 100% 
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Table 4 : Distribution of cases - Clubbing 
 
Clubbing No. Percentage  
Present 35 70% 
Absent  15 30% 
Total  50 100% 
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Table 5 :Distribution of cases among transferrin saturation 
 
Transferrin saturation 
(%) 
No. Percentage 
< 16 35 70% 
>16 15 30% 
Total 50 100% 
 
Transferrin saturation of < 16%  categorized as iron deficient 
Transferrin saturation of > 16%  categorized as iron sufficient 
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Table 6 :Association among cases between - age and iron status 
Age  (yrs) Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 1   6 50 6  50 12 100 
1 to 6 20 83.3 4 16.7 24 100 
6 to 12 9 64.3 5 35.7 14 100 
Total  35  15  50  
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 4.535
a
 2 .104 
Likelihood Ratio 4.575 2 .102 
Linear-by-Linear 
Association 
.461 1 .497 
N of Valid Cases 50   
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 Table 7: Association among cases between - sex and iron status 
 
Sex  Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
Male   16 64 9  36 25 100 
Female  19 76 6 24 25 100 
Total  35 15  50  
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .857
a
 1 .355   
Continuity 
Correction
b
 
.381 1 .537 
  
Likelihood Ratio .862 1 .353   
Fisher's Exact Test    .538 .269 
Linear-by-Linear 
Association 
.840 1 .359 
  
N of Valid Cases 50     
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Table 8:Association between Hemoglobin(gm%) and iron status 
 
Hemoglobin 
(gm%) 
Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 11.5  4 50 4  50 8 100 
11.5 – 14 11 64.7 6 35.3 17 100 
>14 20 80 5 20 25 100 
Total  35  15  50  
 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 2.941
a
 2 .230 
Likelihood Ratio 2.902 2 .234 
Linear-by-Linear 
Association 
2.882 1 .090 
N of Valid Cases 50   
 
 
 
 
 
 
 
 
 
 
 
  
50
64.7
80
50
35.3
20
0
10
20
30
40
50
60
70
80
90
< 11.5 11.5 - 13.9 > 14
Iron deficient
Iron sufficient
Association between Hemoglobin(gm%) and iron status 
 
 
 
Table 9:Association among cases between - Hematocrit(%) and iron 
status 
 
Hematocrit(%) Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 34  2 50 2  50 4 100 
34 -60 20 60.6 13 39.4 33 100 
>60 13 100 0 0 13 100 
Total  35  15  50  
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 7.720
a
 2 .021 
Likelihood Ratio 11.290 2 .004 
Linear-by-Linear 
Association 
6.703 1 .010 
N of Valid Cases 50   
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 Table 10:Association among cases between - MCV (fl) and iron status 
 MCV(fl) Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 75 29 82.9 6  17.1 35 100 
75 -100 6 42.9 8 57.1 14 100 
>100 0 0 1 100 1 100 
Total  35  15  50  
 
Chi- square test Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 10.000
a
 2 .007 
Likelihood Ratio 9.895 2 .007 
Linear-by-Linear 
Association 
9.797 1 .002 
N of Valid Cases  50   
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Table 11 :Associationamong cases between -  MCH(pg) and iron status 
 
MCH(pg) Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
<24 27 73 10 27 37 100 
>24  8 61.5 5 38.5 13 100 
Total  35 15  50  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .599
a
 1 .439   
Continuity 
Correction
b
 
.178 1 .673 
  
Likelihood Ratio .582 1 .445   
Fisher's Exact Test    .493 .330 
Linear-by-Linear 
Association 
.587 1 .444 
  
N of Valid Cases 50     
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Table 12 :Association between MCHC(g/dl) and iron status 
 
MCHC(g/dl) Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
<31 19 70.4 8 29.6 27 100 
>31  16 69.6 7 30.4 23 100 
Total  35 15  50  
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .004
a
 1 .951   
Continuity 
Correction
b
 
.000 1 1.000 
  
Likelihood Ratio .004 1 .951   
Fisher's Exact Test    1.000 .596 
Linear-by-Linear 
Association 
.004 1 .951 
  
N of Valid Cases 50     
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Table 13.Association  between - serum iron (mg%) and iron  status 
Serum iron Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 50 20 100 0 0 20 100 
50 -100 15 65.2 8 34.8 23 100 
>100 0 0 7 100 7 100 
Total  35  15  50  
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 25.155
a
 2 .000 
Likelihood Ratio 31.366 2 .000 
Linear-by-Linear 
Association 
23.474 1 .000 
N of Valid Cases 50   
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Table 14:Association between  TIBC and iron status 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 1.168
a
 1 .280   
Continuity 
Correction
b
 
.582 1 .445 
  
Likelihood Ratio 1.205 1 .272   
Fisher's Exact Test    .351 .225 
Linear-by-Linear 
Association 
1.145 1 .285 
  
N of Valid Cases 50     
TIBC Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 250 1 100 0 0 1 100 
250 -450 19  11  30 100 
>450 15 78.9 4 21.1 19 100 
Total  35  15  50  
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Table 15 :Association between RDW(%) and iron status 
RDW Iron deficient Iron sufficient Total 
No . % No. % No. % 
11.5-14.5 7 87.5 1 12.5 8 100 
>14.5 28 66.7 15 33.3 42 100 
Total 35 15  50  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 1.389
a
 1 .239   
Continuity 
Correction
b
 
.574 1 .449 
  
Likelihood Ratio 1.591 1 .207   
Fisher's Exact Test    .407 .232 
Linear-by-Linear 
Association 
1.361 1 .243 
  
N of Valid Cases 50     
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Table 16 :Association between Sr.ferritin  and iron status 
 
Serum ferritin Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 15 27 100 0 0 27 100 
>15 8 34.8 15 65.2 23 100 
Total  35 15  50  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 25.155
a
 1 .000   
Continuity 
Correction
b
 
22.146 1 .000 
  
Likelihood Ratio 31.366 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
24.652 1 .000 
  
N of Valid Cases 50     
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Table 17:Association between  RBC Count (million/cu.mm)  and iron 
status 
 RBC count Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 4.5 11 55 9 45 20 100 
>4.5 24 80 6 20 30 100 
Total  35 15  50  
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 3.571
a
 1 .059   
Continuity 
Correction
b
 
2.480 1 .115 
  
Likelihood Ratio 3.537 1 .060   
Fisher's Exact Test    .114 .058 
Linear-by-Linear 
Association 
3.500 1 .061 
  
N of Valid Cases 50     
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Table 18: Association between  Platelet Count (lakhs/cu.mm)  and iron 
status 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 4.108
a
 2 .128 
Likelihood Ratio 3.845 2 .146 
Linear-by-Linear 
Association 
.522 1 .470 
N of Valid Cases 50   
 
 
Platelet count Iron deficient Iron sufficient    Total  
No .  %  No.   %  No.  % 
< 1.5 3 42.9 4 57.1 7 100 
1.5 -4.0 30 76.9 9 23.1 39 100 
>4 2 50 2 50 4 100 
Total  35  15  50  
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DISCUSSION  
 
In this study ,50 children with congenital cyanotic heart disease 
were included and investigated by doing complete blood count and iron 
profile . Based on the transferrin saturation ,they were categorised into two 
groups as iron deficient and iron sufficient. Children who had a transferrin 
saturation level < 16% were grouped as iron deficient and those who had a 
transferrin saturation level >16% were grouped as iron sufficient. 
In table 1(age distribution among cases), out of 50 children included 
in this study, 12 (24%)  were less than 1 year ,24(48%) children were 
between 1 to 6 years  and 14 (28%) children were in between  6 to 12 
years. Most of the children were in the age group of  1 to 6 years. 
In table 2 (sex distribution among cases) ,Among the total of 50 
patients,25(50% )were male and 25(50%) were female. 
 In table 3: Distribution of cyanosis among cases : 
40 cases(80%) have cyanosis, 10 cases(20%) donot have cyanosis.         
 In table 4 :Distribution of clubbing among cases : 
35 cases(70%) have clubbing, 15 cases(30%) donot have clubbing.         
 
 
 
In table 5,Based on transferrin saturation, children were grouped 
into iron deficient and iron sufficient.35(70%) children who had transferrin 
saturation of < 16% and 15(30%) children had transferrin saturation of 
>16%. In this study the prevalence of iron deficiency among children 
with cyanotic congenital heart disease was 70%. In other similar studies, 
cemilebanu et al
(37)
the prevalence of iron deficiency anemia  was 63.6% 
and Lango et al
(40)
 the prevalence  was 16.9%. 
In table 6, we see that, out of 12 children who were <1 year of age, 
6(50%) were iron deficient and 6(50%) were iron sufficient, and out of 24 
patients between 1-6 years age group,20 (83.3%) were iron deficient and 4 
(16.7%) were iron sufficient. Among 14 children between 6-12 years age 
group,9(64.3%) were iron deficient and 5(35.7%) were iron sufficient. 
This shows that iron deficiency is more common between 1-6 years. This 
finding is consistent with the finding of NFHS 3, where maximum number 
of children with iron deficiency anaemia lie between 6 -35 months of age. 
But there was no statistical association between age of the patient and iron 
status (p=0.0104.). 
From table 7,among 25 male children,16 (64%) were iron deficient 
and 9(36%) were iron sufficient .Out of 25 female children 19(76%) were 
iron deficient and 7 (24%) were iron sufficient. He we observed females 
 
 
are more prone to develop iron deficiency anaemia. But there was no 
statistical association between sex of the patient and iron status (p=0.355) 
Table 8 shows, out of 8 children who had Hemoglobin of < 11.5 
gm%,4 (50%) were iron deficient and 4(50%) were iron sufficient.Out of 
17 children who had haemoglobin between 11.5-14gm%,11(64.7%) were  
iron deficient and 6(35.3%) were iron sufficient. Out of 25 children who 
had haemoglobin >14gm%,20(80%) were  iron deficient and 5(20%) were 
iron sufficient. Even in children with a haemoglobin of > 14 , 80 % were 
iron deficient . There is no statistical association between haemoglobin and 
iron status (p= 0.230). Hence haemoglobin was not a significant parameter 
to determine iron deficiency. This finding is consistent with the study done 
by  cemilebanu et al(37) and david et al
(44)
  where haemoglobin was not 
considered as a significant parameter in the diagnosis of iron deficiency 
anaemia. 
Table 9 shows ,out of 4 children who had haematocrit of < 34,2  
(50%) were iron deficient and 2(50%) were iron sufficient. out of 33 
children who had haematocrit between 34-60,20(60.6%) were  iron 
deficient and 13(39.4%) were iron sufficient. out of 13 children who had 
haematocrit of >60%,13 all (100%) were  iron deficient . Here  we observe 
that in patients with a haematocrit  of > 60%, 100 % are iron deficient. 
There is statistical association between haematocrit and iron status 
 
 
(p=0.021). This is similar to olcay et al
(38)
 where haematocrit was a 
significant parameter in determining iron status.(p <0.05) 
Table 10 shows ,Out of 35 children who had MCV level of < 75,29  
(82.9%) were iron deficient and 6(17.1%) were iron sufficient. Out of 14 
children who had MCV level between 75-100 ,6(42.9%) were  iron 
deficient and 8(57.1%) were iron sufficient,and only one child (100%) had 
MCV level of >100 fl. there was statistical significant  association between 
MCV level  of the patient and iron status (p=0.07) . This is comparable to 
study done by L.Olcay et al
(38)
 and cemilebanu et al
(37)
 where they 
concluded MCV is an important indicator of iron deficiency in CCHD. 
Table 11 shows ,Out of 37 children who had MCH of < 24,27 (73%) 
were iron deficient and 10(27%) were iron sufficient. out of 13 children 
who had MCH of >24,8(61.5%) were  iron deficient and 5(38.5%) were 
iron sufficient.There was no statistical significant  association between 
MCH  level  of the patient and iron status (p= 0.439). This was similar to 
study done by L.Olcay et al
(38)
 and M Gaiha et al
(45)
. 
Table 12 shows, out of 27 children who had MCHC of < 31,19  
(70.4%) were iron deficient and 8(29.6%) were iron sufficient. out of 23 
children who had MCHC of >31,16(69.6%) were  iron deficient and 
7(30.4%) were iron sufficient. There was no statistical significant  
association between MCHC level  of the patient and iron status (p=0.951) . 
 
 
This was in contrast to Drossos
(39)
 et al where they concluded MCHC is a 
precise indicator for diagnosis of iron deficiency anaemia in children with 
cyanotic heart disease. 
Table 13 shows, out of 20 children who had serum iron level of < 50 
mg%, All (100%) were iron deficient. out of 23 children who had serum 
ironlevel between 50-100 ,15(65.2%) were  iron deficient and 8(34.8%) 
were iron sufficient, and 7 children  (100%) had serum iron level of >100 
mg%. There was statistical significant  association between serum iron 
level  of the patient and iron status (p=0.000). This is comparable to study 
done by Gaiha  et al 
(45)
and Cemilebanu et al
(38)
 where they concluded 
serum iron is an important indicator of iron deficiency in CCHD. 
Table 14 shows, only one(100%) child  had TIBC of < 250 ,who 
was iron deficient. out of 30 children who had TIBC between 250-
450,19(63.3%) were  iron deficient and 11(36.7%) were iron sufficient. out 
of 19 children who had TIBC of >450,15(78.9%) were  iron deficient and 
4(21.1%) was iron sufficient. There was  no statistical significant  
association between serum iron level  of the patient and iron status 
(p=0.280). 
Table 15 shows, out of 8 children who had RDW between          
11.5-14.5, 7(87.5%) were iron deficient and 1(12.5%) were iron sufficient. 
out of 42 children who had RDW of >14.5, 28(66.7%) were  iron deficient 
 
 
and 14(33.3%) were iron sufficient. There was  no statistical significant  
association between RDW  of the patient and iron status (p=0.239). 
Table 16 shows, out of 27 children who had serum ferritin between  
< 15, 27 all (100%) were iron deficient .Out of 23 children who had Serum 
ferritin of >15,8(34.8%) were  iron deficient and 15(65.2%) were iron 
sufficient. There was  statistical significant  association between serum 
ferritin  of the patient and iron status (p=0.000). 
Table 17shows, out of 20 children who had RBC count  < 4.5 ,11(55 
%) were iron deficient and 9(45%) were iron sufficient. out of 30 children 
who had RBC count of >4.5,24(80%) were  iron deficient and 15(65.2%) 
were iron sufficient. There was  no statistical significant  association 
between RBC count  of the patient and iron status (p=0.059). 
Table 18  shows ,Out of 7 children who had platelet count of < 1.5,3 
(42.9%) were iron deficient and 4(57.1%) were iron sufficient. out of 39 
children who had platelet count of 1.5-4,30(76.9%) were  iron deficient 
and 9(23.1%) were iron sufficient. Out of 4 children who had a platelet 
count of >4,2(50%) were iron sufficient and 2(50%) were iron sufficient. 
There was no statistical significant  association between  platelet count  of 
the patient and iron status (p=0.128).  
 
 
 
CONCLUSION 
 
1. Prevalence of iron deficiency anaemia in children with cyanotic 
congenital heart disease  was 70% 
2. Iron deficiency anaemia  was more common among 1 – 6 
yrs(83.3%) and female children(76%), though there was no 
statistical  association. 
3. 82.9 % of cases with iron deficiency  anaemia  had MCV < 72 
fl. There was  statistical significant  association between MCV 
level  of the patient and iron status (p=0.07). 
4. Raised HCT> 60% was found in 100 %(13 cases) of children  
with iron deficiency anaemia in children with cyanotic 
congenital heart disease . There was  statistical significant  
association between HCT  of the patient and iron status 
(p=0.021). 
5. 20(100%) of children  who had sr .iron < 50 mg/dl were iron 
deficient . There was  statistical significant  association between 
iron status  of the patient and iron status (p=0.00). 
6. 27(100%) of children  who had sr .ferritin < 15 ng/dl were  iron 
deficient . There was  statistical significant  association between 
serum ferritin status  of the patient and iron status (p=0.00). 
 
 
SUMMARY 
 
Iron deficiency anaemia is a common nutritional anaemia, which is 
often underestimated in children with cyanotic congenital heart disease. 
Presence of microcytic anaemia in cyanotic congenital heart disease can 
lead to hyperviscosity which can further lead to cerebrovascular accidents 
and death. Hence prevention of anaemia in cyanotic congenital heart 
disease patients is extremely important. 
Definitive tests like serum ferritin, serum iron,TIBC are expensive 
and not freely available. Hence we made an attempt to study simple tests to 
determine the iron status in children with cyanotic congenital heart disease. 
50 children with cyanotic congenital heart disease were enrolled in 
the study. Based on the transferrin saturation level, a cut off value of < 
16% was taken to be iron deficient. This was compared against age ,sex 
,haemoglobin, haematocrit, RDW, MCV, MCH, MCHC, Platelet count 
,serum iron, TIBC and serum ferritin. 
Age distribution among cases :  
12 (24%)  - < 1 year ,24(48%) -1 to 6 years  and 14 (28%) - 6 to 12 
years. 
 
 
 
Sex distribution among cases : 
25(50% )- male and 25(50%) -female . 
Based on transferrinsaturation: 
Iron deficient - 35(70%) and iron sufficient- 15(30%) 
Distribution of cyanosis among cases : 
40 cases(80%) have cyanosis, 10 cases(20%) donot have cyanosis.         
Distribution of clubbing among cases : 
35 cases(70%) have clubbing, 15 cases(30%) donot have clubbing.        
Hemoglobin and iron status : 
Hb%  < 11.5 gm%-4(50%) were iron deficient and 4(50%) were 
iron sufficient, Between 11.5-14gm% - 11(64.7%) were  iron deficient and 
6(35.3%) were iron sufficient ,>14gm% ,20(80%) were  iron deficient and 
5(20%) were iron sufficient. 
Haematocrit  and iron status : 
 HCT < 34,2  (50%) were iron deficient and 2(50%) were iron 
sufficient, between 34-60,20(60.6%) were  iron deficient and 13(39.4%) 
were iron sufficient,>60%,13(100%) were  iron deficient . 
 
 
 
MCV level and iron status:  
MCV< 75,29  (82.9%) were iron deficient and 6(17.1%) were iron 
sufficient, between 75-100 ,6(42.9%) were  iron deficient and 8(57.1%) 
were iron sufficient,and>100 fl - 1 child (100%). 
MCH level and iron status : 
MCH  < 24,27  (73%) were iron deficient and 10(27%) were iron 
sufficient. >24, 8(61.5%) were  iron deficient and 5(38.5%) were iron 
sufficient. 
MCHC and iron status: 
MCHC  < 31,19  (70.4%) were iron deficient and 8(29.6%) were 
iron sufficient,  >31,16(69.6%) were  iron deficient and 7(30.4%) were 
iron sufficient. 
Serum iron level and iron status:  
serum iron  < 50 mg%, 20,all  (100%) were iron deficient, between 
50-100, 15(65.2%) were  iron deficient and 8(34.8%) were iron sufficient, 
and 7 (100%) had serum iron level of >100 mg%. 
 
 
 
 
 
TIBC  and iron status: 
TIBC <250 ,1 child(100%)  iron deficient, Between 250-
450,19(63.3%) were  iron deficient and 11(36.7%) were iron 
sufficient,>450,15(78.94%) were  iron deficient and 4(21.1%) was iron 
sufficient. 
RDW and iron status: 
  RDW between 11.5-14.5 ,7(87.5%) were iron deficient and 
1(12.5%) were iron sufficient, >14.5,28(66.7%) were  iron deficient and 
14(33.3%) were iron sufficient. 
Serum ferritin and iron status: 
 Serum ferritin < 15,27(100%) were iron deficient, >15,8(34.8%) 
were  iron deficient and 15(65.2%) were iron sufficient. 
RBC COUNT and iron status: 
  RBC Count <4.5 ,11(55%) were iron deficient and 9(45%) were iron 
sufficient, >4.5,24(80%) were  iron deficient and 6(20%) were iron 
sufficient. 
 
 
 
 
 
PLATELET COUNT  and iron status: 
Platelet count <1.5 ,3 (42.9%)  iron deficient and 4(57.1) were iron 
sufficient, Between 1.5-4,30(76.9%) were  iron deficient and 9(23.1%) 
were iron sufficient, >4,2(50%) were  iron deficient and 2(50%) was iron 
sufficient. 
Only haematocrit, MCV,serumiron,serum ferritin had  significant 
correlation with iron deficiency in children with cyanotic congenital heart 
disease. 
Hence we concluded Haematocrit And MCV levels can used to 
determine iron deficiency in children with cyanotic congenital heart 
disease in resource poor settings. 
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PROFORMA 
 NAME:     CARDIOLOGY NO: 
 AGE: 
 SEX: 
 ADDRESS: 
 CONSANGUINITY: 
 GENERAL EXAMINATION : 
      yes                no 
CYANOSIS:     
CLUBBING:     
 
 INVESTIGATIONS:  
HAEMOGLOBIN:  
RBC COUNT:  
PLATELET COUNT:  
HAEMATOCRIT:  
MEAN CORPUSCULAR VOLUME:  
 
 
MEAN CORPUSCULAR 
HAEMOGLOBIN CONCENTRATION: 
 
RED CELL DISTRIBUTION WIDTH:  
SERUM IRON:  
TOTAL IRON BINDING CAPACITY:  
SERUM FERRITIN:  
TRANSFERRIN  SATURATION:  
PERIPHERAL SMEAR:  
 
 
ELECTROCARDIOGRAPHY:     
 
2D-ECHO: 
 
CHEST X-RAY: 
 
TREATMENT TAKING: 
COMPLICATION: 
 
 
ABBREVIATIONS 
 
CCHD -  CYANOTIC CONGENITAL HEART DISEASE 
Hb  -  HAEMOGLOBIN 
HCT  -  HAEMATOCRIT  
RBC  - RED BLOOD CELL 
MCV  - MEAN CORPUSCULAR VOLUME 
MCH  -  MEAN CORPUSCULAR HAEMOGLOBIN 
MCHC -  MEAN CORPUSCULAR HAEMOGLOBIN  
CONCENTRATION 
TIBC  -  TOTAL IRON BINDING CAPACITY 
RDW  - RED CELL DISTRIBUTION WIDTH 
sTFR  - TRANSFERRIN SATURATION 
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1 Iyyammal 9 F TOF/dextrocardia 1 1 21.3 10.06 0.55 82.7 82.2 21.2 25.8 25.9 72 375 15 11.6
2 Dinesh Kumar 7 M TOF 1 1 10.1 5.73 3.66 39.7 69.3 17.6 25.4 21.5 18 557 3 10.7
3 vaishnavi 5 F
pul.atresia/LVSD/MAPC
OS SCA 1 1 21.3 9.37 0.8 77.6 82.8 22.7 27.4 26.2 68 477.4 14 13
4 Santha Kumar 6 M DORV,VSD,PS 1 1 15.6 4.33 4.4 45.04 86 29.8 34.7 18.6 48 356 13.8 8.8
5 Muthumuneeswaran 10 M TOF 1 1 20.4 5.67 2.67 60.21 66 22.2 33.9 25 56 428 13.08 8.4
6 Aarthy 2 F DORV,TGA 0 0 22.1 10.26 1.82 79 77 21.5 28 28.5 10 768 1 5.2
7 Pandeeshwari 4.5 F TOF 1 1 15.4 6.05 2.86 48.32 71.22 18.6 31.87 16 46.6 354 12.99 11.5
8 Shrishanth Vijay 2 M Single ventricle,PS 1 1 13.6 4.7 3.28 38 85.1 16.4 30.6 22.4 32 322 10 32.5
9 Uma Maheshwari 8 F TOF 1 1 10.2 3 2.9 36 68 16.2 28.3 19.2 15 535 3 18.8
10 Vignesh kumar 3 M TOF 1 1 17.9 9.8 1.77 68.6 70 18.3 26.1 12.2 14 420 3 10
11 Divya 3 F TOF 1 1 13.2 3.8 2.36 38 59 14.2 35.78 20 28 426 6.57 12
12 Nandagopal 7.5 M DORV 1 1 10.6 2.7 3.28 34.2 76.2 16.4 33.9 22.4 62.22 364.46 17 134
13 RamKumar 2 M TOF 1 0 11.8 3.25 3.24 35 71 23 31.42 16 29.41 250 11.5 9
14 Dhanasree 5 Fch TA &PS 1 1 14.2 3.92 1.88 42.34 60.2 18.2 33.5 13.6 28.2 628 4.49 52
15 Ajay 10m mch DORV,VSD,PA,MAPCA 0 0 11.7 2.86 4.18 36.1 54.6 17.7 32.4 17.7 116.27 382.92 30.36 215
16 Ganesan 10 mch d-TGA,VSD,PS 1 1 14.6 5.7 1.41 53.44 90 24.7 27.4 18.8 96.96 321.96 30.2 158
17 Muniyasamy 4 mch TOF 1 1 22.99 8.86 0.78 74.31 63 25.5 30.9 12.2 62.86 482.36 13.86 15.7
18 Karthikeyan 12 mch TOF 1 1 21 9.01 1.6 73 68.5 22.4 28.5 12.8 52.36 492 10.64 11.1
19 Saravanan 8 mch VSD/ PS 1 1 18.4 7.56 1.9 65.7 69.75 19.53 28.01 60 56.39 428 13.86 13.5
20 Dharaneshwaran 3 mch TOF,MAPCA 1 1 12.6 3.75 4.48 56 68 26 22.5 16 39.36 410.3 9.59 8.4
MASTER CHART
21 Rajesh 1.5 mch LASD,VSD,PS 0 0 11.6 3.62 1.96 32.76 56 22.3 29.9 18.6 28 327.34 8.55 9.5
22 Dhanalakshmi 7 fch TOF 1 1 13.6 4.75 2.36 38 59 14.2 35.78 20 28 426 6.57 6
23 Logavarshini 2.5 fch LVSD,PS 1 1 11.8 3.86 3.24 35 71 23 31.42 16 29.41 255.51 11.51 12
24 Thanga 6.5 fch SA TAPVC,PAH 1 1 12.6 3.45 2.84 38 82 28 37 21 104 506 24 84
25 Sujithra 1 fch TAPVC 0 0 13.7 2.8 0.98 32 51 20 30.68 17 59 356 28 68
26 Vaishnavi 5 fch PDA/VSD/MAPCOS 1 1 16.2 5.2 3.27 56.4 82 21.5 23.86 16 54 596 30.6 92
27 Boomika 1.5 fch SV PS,OS VSD 0 0 9.8 2.14 2.37 35.8 64 18.6 27.3 20.7 171 536 31.95 112
28 Sivapandi 11 mch TGV 1 1 11.7 3.56 4.18 36 78.6 17.7 32.4 17.7 116.27 382.92 30.36 150
29 Dhanalakshmi 2 fch TA/LVSD/ 0 0 21 7.5 2.6 73 68.5 22.4 28.5 22.8 52.36 492 10.64 13.4
30 Arunkumar 7 mch Dextrocardia/DORV 1 1 17.5 6.82 2.5 58.9 87 25.6 29.6 18.7 97.22 389.26 24.07 88
31 Abinayashree 7 m fch VSD/PA,PDA,MAPCOS 0 0 11.5 3.1 2.6 49.1 71.8 22 23.46 18 13.45 328 3.99 7.5
32 Rathinakumar 2.5 mch TA-Type 2b 1 1 13.6 4 2.36 38 59 14.2 35.78 20 28 426 6.57 9.4
33 Ruba 7 m fch LVSD,PA 0 0 9.8 2.5 2.37 35.4 64 18.6 27.3 20.7 171.05 387.72 44.11 76
34 Hariharan 8m mch TOF 0 0 10.62 3.02 0.9 31.4 52.6 16.5 30.9 24.2 62 472 19 102
35 Akalya 8 m fch TOF,PA,MAPCOS 0 0 17.9 8.65 1.05 56 117 20.6 34.6 16 161.76 387.76 41.73 64
36 Vuppili 6 m mch PA/VSD/MAPCOS 0 0 12.2 4.2 3.03 38 69 19.2 32.1 19.6 56.6 462.34 12.24 13.58
37 Sarika 8 m fch C CHD/DORV/VSD 1 0 15.2 5.4 2.11 45.68 71 18.98 33.27 13.6 42 386 10.88 17.42
38 Sudansrinivasan 8 m mch TOF 1 0 14.8 4.8 3.22 43 68 24.4 34.41 22 48.2 380 12.68 30.46
39 Iyyanar 9m mch TA/LVSD/PS 1 0 11.6 3.33 3.28 34.2 58.2 16.4 33.9 22.4 62.22 364.46 17.07 54
40 kannan 1 m TOF 1 1 16.6 5.82 2.3 50 84 24.8 30 17.2 84 351 18.23 81
41 muthu mahalakshmi 8 f TOF 1 1 23.8 9.2 3.12 77 66 24.7 32.6 13.4 60.25 472 12.52 14.82
42 kanagarani 10 m f TGV / MOD, PS 1 1 14.3 4.6 3.42 52 72 21.8 36.4 18 58 416 13.5 13.74
43 chinnaponnu  8 m f TOF 1 1 19.2 7.25 2.67 72 24 26.4 38.2 12.8 54 342 14.8 16.7
44 eswari 4 f DORV/ PS 1 1 22.5 11.2 1.8 84 86.5 23.4 26.2 27 84 412 16 56
45 karrupusamy 1.5 m TGA /PS 1 1 11.4 6.34 2.82 35.6 68.7 18.2 24.6 23 23 587 9 10.4
46 hemalini 2.5 f D TGA 1 1 12.6 7.4 2.9 38 66 25.2 32 19 52 502 12 10.85
47 mareeswaran 10 m m RPA Stenosis/vsd 1 1 13.2 7.8 1.9 42 88 26.4 32.8 14 102 315 18 94
48 vijay 3.5 m TOF 1 1 16.5 8.6 2 60 70 22.5 27 18 54 462 13 11.72
49 rohini 5 f TOF 1 1 10.9 6 2.26 33 64 21 25.6 17 48 512 12.5 12
50 saradha 10 f TOF 1 1 18.4 9.1 3.2 65 58 26.5 29.3 26 59 457 14 12.38
